Your cart is empty.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Chairwoman of the Audit Committee
Member of the Nomination and Governance Committee
Since 2012, elected until 2023
1963, Swiss and British citizen
Education | (IMD, Lausanne), Ph.D. Natural Sciences Molecular Biology (ETH Zurich), Masters Degree, Animal Sciences (ETH Zurich) |
Professional background | |
2014 - 2021 | CEO Solvias Group2, Headquarter in Kaiseraugst, Switzerland |
Since 2012 | Founder and Managing Director of Fibula Medical AG |
2009 - 2011 | Member of the European Commercial Operations Leadership Team and Site Head Novartis Vaccines & Diagnostics, Basel; Head Public Health and Market Access Europe (Marketing & Sales); Board member European Vaccines Manufacturer's Association, Brussels. |
2006 - 2009 | Executive Committee Member, Head M&A/BD&L Division Vaccines & Diagnostics |
2000 - 2006 | Group Head Investor Relations Novartis |
1995 - 2000 | Various roles with increasing responsibility in R&D and Finance |
Financial Expertise | |
CEO of Solvias AG2; Head Investor Relations Group, Novartis from 2000 to 2006, reporting directly to CFO and Head of Treasury, Member of the Disclosure Committee Novartis, Head Mergers and Acquisitions, Division Vaccines & Diagnostics, Novartis | |
Other activities | |
BBI Group2, Member of the Board Nonprofit organizations: SMG (Swiss Management Association)2, Member of the Board; IMD Foundation2, Member of the Board |
1 public company
2 private company